Treatment patterns in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis

Author
Hitier, S.
Ozguroglu, M.
Karavasilis, V.
Ecstein-Fraisse, E. B.
Bensfia, S.
Akaza, H.
Procopio, G.
Pripatnanont, C.
Facchini, G.
Fava, S.
Wheatley, D.
Leung, K. C.
Butt, M.
Silva, A.
Castillo, L.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/122431
https://doi.org/10.1016/s0959-8049(16)31368-5
Collections